Zobrazeno 1 - 6
of 6
pro vyhledávání: '"K M, Szewczyk"'
Autor:
M C Plank, Marcie J. Hursting, J P Steiner, Bryan T. Butman, M L Bell, K M Szewczyk, F A Dombrose, Bryant M. Moore
Publikováno v:
Clinical Chemistry. 39:583-591
Prothrombin fragment 1.2 (F1.2) is an activation peptide generated during a critical event of blood coagulation, the conversion of prothrombin to thrombin. As a marker of thrombin generation, F1.2 has clinical potential in assessing thrombotic risk a
Autor:
K M Szewczyk, Paul J. Braun
Publikováno v:
Thrombosis and Haemostasis. 68:160-164
SummaryPlasma levels of total prothrombin and fully-carboxylated (native) prothrombin were compared with results of prothrombin time (PT) assays for patients undergoing oral anticoagulant therapy. Mean concentrations of total and native prothrombin i
Publikováno v:
Archives of pathologylaboratory medicine. 122(1)
Immunoassays for prothrombin fragment 1.2 (F1.2) provide a specific measure of thrombin generation and offer potential value in detecting activation of the coagulation system and monitoring anticoagulant therapy. To standardize laboratory measurement
Autor:
K M, Szewczyk
Publikováno v:
Neurologia i neurochirurgia polska. 29(4)
The purpose of the study was to investigate the dynamics of glucose and fructose concentrations in the blood changes and phosphohexose isomerase activity (PHI) in serum of unfed or after intravenous glucose injection patients, with acute cerebrovascu
Autor:
M J, Hursting, B T, Butman, J P, Steiner, B M, Moore, M C, Plank, K M, Szewczyk, M L, Bell, F A, Dombrose
Publikováno v:
Clinical chemistry. 39(4)
Prothrombin fragment 1.2 (F1.2) is an activation peptide generated during a critical event of blood coagulation, the conversion of prothrombin to thrombin. As a marker of thrombin generation, F1.2 has clinical potential in assessing thrombotic risk a
Autor:
P J, Braun, K M, Szewczyk
Publikováno v:
Thrombosis and haemostasis. 68(2)
Plasma levels of total prothrombin and fully-carboxylated (native) prothrombin were compared with results of prothrombin time (PT) assays for patients undergoing oral anticoagulant therapy. Mean concentrations of total and native prothrombin in non-a